What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News COSMIC-311 clinical trial : Exelixis enrolls patients to study cabozantinib in phase 3 thyroid cancer trial COSMIC-311 clinical trial : US biotech company Exelixis has enrolled the first 100 patients in a phase 3… bypharmanewsdailyFebruary 26, 2020
